Document ID: chunk:federal_register_of_legislation:C2012A00087:clause:3_18
Version: federal_register_of_legislation:C2012A00087
Segment Type: clause
Provision Reference: sch 3 cl 18
Character Range: 58263–59789

18  Transitioning subordinate legislation relating to prescriber bag supplies
(1) A legislative instrument that:
 (a) was made for the purposes of subsection 85(2A) of the National Health Act; and
 (b) declared that the drug methoxyflurane can only be supplied under special arrangements under section 100 of the National Health Act; and
 (c) was in force immediately before the commencement day;
continues in force (and may be dealt with) on and after that day as if:
 (d) it had been made for the purposes of subsection 85(2AA) of the National Health Act (as amended by this Act); and
 (e) it declared that methoxyflurane can only be supplied under section 93 of the National Health Act (as amended by this Act).
(2) Regulations that:
 (a) were made for the purposes of section 93AA of the National Health Act; and
 (b) were in force immediately before the commencement day;
continue in force (and may be dealt with) on and after that day as if they had been made for the purposes of sections 93AA and 93AB of the National Health Act (as amended by this Act).
(3) A legislative instrument that:
 (a) was made for the purposes of section 93AA of the National Health Act; and
 (b) was in force immediately before the commencement day;
continues in force (and may be dealt with) on and after that day as if it had been made for the purposes of section 93AB of the National Health Act (as amended by this Act).

[Minister's second reading speech made in—
House of Representatives on 23 May 2012
Senate on 18 June 2012]
(78/12)